UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
19.10
+1.07 (5.93%)
At close: Apr 8, 2026, 4:00 PM EDT
18.72
-0.38 (-1.99%)
After-hours: Apr 8, 2026, 7:31 PM EDT

UroGen Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9301,132450487205214
Market Cap Growth
66.31%151.77%-7.71%137.54%-3.96%-46.52%
Enterprise Value
939.461,140336.47449.78204.32124.88
Last Close Price
19.1023.4210.6515.008.879.51
PE Ratio
--7.34-3.60-4.23-1.84-1.92
PS Ratio
8.4710.314.985.893.194.45
PB Ratio
--10.74-51.09-7.47-2.3025.39
P/TBV Ratio
-8.71-10.68-51.87-6.63-2.2625.26
P/FCF Ratio
--6.96-4.63-6.36-2.34-2.49
P/OCF Ratio
--6.97-4.65-6.38-2.34-2.52
EV/Sales Ratio
8.5610.393.725.443.172.60
EV/EBITDA Ratio
--9.31-3.52-7.05-2.65-1.38
EV/EBIT Ratio
--9.13-3.48-6.86-2.59-1.35
EV/FCF Ratio
--7.01-3.47-5.87-2.33-1.46
Debt / Equity Ratio
-1.22-1.22-14.02-1.52-1.110.05
Debt / EBITDA Ratio
-1.05-1.05-1.29-1.56-1.280.00
Debt / FCF Ratio
-0.79-0.79-1.27-1.30-1.130.00
Net Debt / Equity Ratio
-0.07-0.0712.870.580.01-10.55
Net Debt / EBITDA Ratio
-0.06-0.061.190.590.010.98
Net Debt / FCF Ratio
-0.05-0.051.170.490.011.04
Asset Turnover
0.450.450.390.530.500.40
Inventory Turnover
0.970.971.191.871.671.52
Quick Ratio
3.313.315.594.884.714.51
Current Ratio
4.014.016.015.425.395.11
Return on Equity (ROE)
268.63%268.63%342.83%132.29%271.24%-211.55%
Return on Assets (ROA)
-51.39%-51.39%-42.67%-43.42%-62.91%-77.36%
Return on Invested Capital (ROIC)
-501.80%-501.80%-791.43%-469.89%-604.58%-1562.88%
Return on Capital Employed (ROCE)
-63.41%-63.41%-50.03%-50.65%-75.61%-93.25%
Earnings Yield
-16.51%-13.62%-27.79%-23.67%-54.23%-52.16%
FCF Yield
-17.50%-14.37%-21.58%-15.71%-42.80%-40.09%
Buyback Yield / Dilution
-12.22%-12.22%-48.70%-26.43%-2.06%-2.60%
Total Shareholder Return
-12.22%-12.22%-48.70%-26.43%-2.06%-2.60%
Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q